Literature DB >> 6362093

Angiographic findings in a young man with recurrent stroke and positive fluorescent treponemal antibody (FTA).

M S Aldrich, J M Burke, S M Gulati.   

Abstract

A young man with a history of two strokes was found to have serologic evidence of a prior syphilitic infection, abnormal spinal fluid, and angiographic evidence of diffuse intracranial and extracranial angiopathy which we believe was due to tertiary syphilis, although his use of oral amphetamines cannot be ruled out as a contributing factor. This is the first reported case in which angiography has demonstrated both intracranial and extracranial disease arterial disease due to neurosyphilis. Since syphilis can produce diffuse cerebral arterial changes, this diagnosis should be considered in young patients with stroke even when non-treponemal serologic tests are negative.

Entities:  

Mesh:

Year:  1983        PMID: 6362093     DOI: 10.1161/01.str.14.6.1001

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  4 in total

1.  Cerebral angiopathy and recurrent strokes following Borrelia burgdorferi infection.

Authors:  P A Uldry; F Regli; J Bogousslavsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

Review 2.  Neurosyphilis in disguise.

Authors:  Ammar Jum'ah; Hassan Aboul Nour; Mohammad Alkhoujah; Sohaib Zoghoul; Lara Eltous; Daniel Miller
Journal:  Neuroradiology       Date:  2021-10-19       Impact factor: 2.804

3.  Early symptoms and outcome of Listeria monocytogenes rhombencephalitis: 14 adult cases.

Authors:  P A Uldry; T Kuntzer; J Bogousslavsky; F Regli; J Miklossy; J Bille; P Francioli; R Janzer
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

4.  Bilateral internal carotid artery dissection associated with prior syphilis: a case report and review of the literature.

Authors:  Antonio Marangi; Giuseppe Moretto; Manuel Cappellari; Nicola Micheletti; Giampaolo Tomelleri; Paolo Bovi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-10       Impact factor: 2.570

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.